Cirrus Logic, Inc. (CRUS) Insider Trading
Insiders sold $13.6M and bought nothing on the open market.
92% of the selling was scheduled in advance under 10b5-1 plans. EVP, Global Operations Justin E Dougherty sold $429k on Feb 11, 34% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2021.
Get an email when CRUS's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Oct 20 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 1,166 | $107.75 | $126k | 9.0% | Form 4 |
| Sep 21 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 1,166 | $119.00 | $139k | 8.3% | Form 4 |
| Aug 20 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 1,166 | $117.89 | $137k | 7.7% | Form 4 |
| Jul 20 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 1,166 | $138.57 | $162k | 7.1% | Form 4 |
| Jul 1 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 1,458 | $145.97 | $213k | 8.2% | Form 4 |
| Jun 29 | Andrew Brannan EVP, Worldwide Sales | Sold10b5-1 plan | 6,464 | $144.71 | $935k | 47% | Form 4 |
| Jun 22 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 1,170 | $168.23 | $197k | 6.7% | Form 4 |
| Jun 3 | Scott Thomas EVP, General Counsel | Sold10b5-1 plan | 1,300 | $180.04 | $234k | 4.0% | Form 4 |
| Jun 2 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 3,907 | $168.54 | $658k | 18% | Form 4 |
| May 29 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 11,171 | $171.65 | $1.92M | 39% | Form 4 |
| May 29 | Andrew Brannan EVP, Worldwide Sales | Sold10b5-1 plan | 1,645 | $175.75 | $289k | 19% | Form 4 |
| May 21 | Justin E Dougherty EVP, Global Operations | SoldNo plan | 2,000 | $166.50 | $333k | 31% | Form 4 |
| May 20 | Alexander M Davern Director | SoldNo plan | 1,000 | $159.00 | $159k | 4.6% | Form 4 |
| May 8 | John Forsyth CEO | Sold10b5-1 plan | 5,000 | $170.41 | $852k | 6.7% | Form 4 |
| Apr 9 | Scott Thomas EVP, General Counsel | Sold10b5-1 plan | 9,942 | $160.11 | $1.59M | 25% | Form 4 |
| Feb 20 | Alexander M Davern Director | SoldNo plan | 1,000 | $140.00 | $140k | 4.4% | Form 4 |
| Feb 13 | Scott Thomas EVP, General Counsel | Sold10b5-1 plan | 3,239 | $141.63 | $459k | 9.6% | Form 4 |
| Feb 11 | Justin E Dougherty EVP, Global Operations | SoldNo plan | 3,000 | $143.16 | $429k | 34% | Form 4 |
| Feb 9 | Carl Jackson Alberty EVP, MSP | Sold10b5-1 plan | 3,648 | $142.09 | $518k | 8.6% | Form 4 |
| Feb 4 | John Forsyth CEO | Sold10b5-1 plan | 21,806 | $135.15 | $2.95M | 23% | Form 4 |
| Nov 14, 2025 | Andrew Brannan EVP, Worldwide Sales | Sold10b5-1 plan 3 parts | 8,913 | $119.06 average | $1.06M | 60% | Form 4 |
| Nov 7, 2025 | Carl Jackson Alberty EVP, MSP | Sold10b5-1 plan | 1,000 | $116.65 | $117k | 2.6% | Form 4 |
| Oct 20, 2025 | Scott Thomas EVP, General Counsel | Sold10b5-1 plan | 734 | $131.25 | $96k | 2.7% | Form 4 |
| Sep 18, 2025 | Scott Thomas EVP, General Counsel | Sold10b5-1 plan | 11,089 | $121.49 | $1.35M | 30% | Form 4 |
| Sep 17, 2025 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan 3 parts | 9,162 | $120.00 average | $1.1M | 40% | Form 4 |
| Sep 15, 2025 | Denise Grode EVP, CHRO | Sold10b5-1 plan | 2,202 | $116.87 | $257k | 28% | Form 4 |
| Sep 2, 2025 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 10,000 | $111.78 | $1.12M | 42% | Form 4 |
| Aug 29, 2025 | Denise Grode EVP, CHRO | Sold10b5-1 plan | 2,208 | $114.36 | $253k | 22% | Form 4 |
| Aug 12, 2025 | Justin E Dougherty EVP, Global Operations | SoldNo plan | 1,542 | $108.08 | $167k | 24% | Form 4 |
| Aug 8, 2025 | Carl Jackson Alberty EVP, MSP | Sold10b5-1 plan | 2,000 | $100.35 | $201k | 4.8% | Form 4 |
| Jun 3, 2025 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 10,000 | $100.00 | $1M | 42% | Form 4 |
| Jun 3, 2025 | Carl Jackson Alberty EVP, MSP | Sold10b5-1 plan | 2,000 | $100.00 | $200k | 4.6% | Form 4 |
| May 21, 2025 | Alexander M Davern Director | SoldNo plan | 1,000 | $105.63 | $106k | 4.6% | Form 4 |
| May 9, 2025 | Justin E Dougherty EVP, Global Operations | SoldNo plan | 3,838 | $100.12 | $384k | 38% | Form 4 |
| Mar 3, 2025 | Scott Thomas EVP, General Counsel | Sold10b5-1 plan | 3,000 | $103.76 | $311k | 10% | Form 4 |
| Feb 3, 2025 | Jeffrey W Baumgartner EVP, R&D | Sold10b5-1 plan | 2,051 | $100.00 | $205k | 20% | Form 4 |
| Nov 19, 2024 | Jeffrey W Baumgartner VP, R&D | Sold10b5-1 plan | 5,542 | $101.05 | $560k | 35% | Form 4 |
- Oct 2010b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 1,166 at $107.75$126k9.0% of stake
- Sep 2110b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 1,166 at $119.00$139k8.3% of stake
- Aug 2010b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 1,166 at $117.89$137k7.7% of stake
- Jul 2010b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 1,166 at $138.57$162k7.1% of stake
- Jul 110b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 1,458 at $145.97$213k8.2% of stake
- Jun 2910b5-1 planAndrew BrannanEVP, Worldwide Sales · sold 6,464 at $144.71$935k47% of stake
- Jun 2210b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 1,170 at $168.23$197k6.7% of stake
- Jun 310b5-1 planScott ThomasEVP, General Counsel · sold 1,300 at $180.04$234k4.0% of stake
- Jun 210b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 3,907 at $168.54$658k18% of stake
- May 2910b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 11,171 at $171.65$1.92M39% of stake
- May 2910b5-1 planAndrew BrannanEVP, Worldwide Sales · sold 1,645 at $175.75$289k19% of stake
- May 21No planJustin E DoughertyEVP, Global Operations · sold 2,000 at $166.50$333k31% of stake
- May 20No planAlexander M DavernDirector · sold 1,000 at $159.00$159k4.6% of stake
- May 810b5-1 planJohn ForsythCEO · sold 5,000 at $170.41$852k6.7% of stake
- Apr 910b5-1 planScott ThomasEVP, General Counsel · sold 9,942 at $160.11$1.59M25% of stake
- Feb 20No planAlexander M DavernDirector · sold 1,000 at $140.00$140k4.4% of stake
- Feb 1310b5-1 planScott ThomasEVP, General Counsel · sold 3,239 at $141.63$459k9.6% of stake
- Feb 11No planJustin E DoughertyEVP, Global Operations · sold 3,000 at $143.16$429k34% of stake
- Feb 910b5-1 planCarl Jackson AlbertyEVP, MSP · sold 3,648 at $142.09$518k8.6% of stake
- Feb 410b5-1 planJohn ForsythCEO · sold 21,806 at $135.15$2.95M23% of stake
- Nov 14, 202510b5-1 planAndrew BrannanEVP, Worldwide Sales · sold 8,913 at avg $119.06$1.06M60% of stake
- Nov 7, 202510b5-1 planCarl Jackson AlbertyEVP, MSP · sold 1,000 at $116.65$117k2.6% of stake
- Oct 20, 202510b5-1 planScott ThomasEVP, General Counsel · sold 734 at $131.25$96k2.7% of stake
- Sep 18, 202510b5-1 planScott ThomasEVP, General Counsel · sold 11,089 at $121.49$1.35M30% of stake
- Sep 17, 202510b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 9,162 at avg $120.00$1.1M40% of stake
- Sep 15, 202510b5-1 planDenise GrodeEVP, CHRO · sold 2,202 at $116.87$257k28% of stake
- Sep 2, 202510b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 10,000 at $111.78$1.12M42% of stake
- Aug 29, 202510b5-1 planDenise GrodeEVP, CHRO · sold 2,208 at $114.36$253k22% of stake
- Aug 12, 2025No planJustin E DoughertyEVP, Global Operations · sold 1,542 at $108.08$167k24% of stake
- Aug 8, 202510b5-1 planCarl Jackson AlbertyEVP, MSP · sold 2,000 at $100.35$201k4.8% of stake
- Jun 3, 202510b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 10,000 at $100.00$1M42% of stake
- Jun 3, 202510b5-1 planCarl Jackson AlbertyEVP, MSP · sold 2,000 at $100.00$200k4.6% of stake
- May 21, 2025No planAlexander M DavernDirector · sold 1,000 at $105.63$106k4.6% of stake
- May 9, 2025No planJustin E DoughertyEVP, Global Operations · sold 3,838 at $100.12$384k38% of stake
- Mar 3, 202510b5-1 planScott ThomasEVP, General Counsel · sold 3,000 at $103.76$311k10% of stake
- Feb 3, 202510b5-1 planJeffrey W BaumgartnerEVP, R&D · sold 2,051 at $100.00$205k20% of stake
- Nov 19, 202410b5-1 planJeffrey W BaumgartnerVP, R&D · sold 5,542 at $101.05$560k35% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Semiconductors & Related Devices
Spot a number that looks wrong? Check it in CRUS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CRUS
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.